Can Universal Health's (UHS) Latest Buyout Drive Growth?

Universal Health Services, Inc.UHS recently announced that it has completed the acquisition of Cambian Group, PLC's Adult Services Division.

Universal Health is expected to have paid a total purchase price of £377 million ($464 million) for this transaction. The company's main objective behind acquiring the Cambian Group asset was to establish its foothold in the U.K., where the operations of the acquiree are mainly centered.

Shares of Universal Health have been underperforming since the beginning of this year. The stock has lost 11.2% year to date, compared with the Zacks categorized Hospitals industry's decline of 9%. We expect the latest acquisition to not only help the company expand in the U.K market but also generate confidence among shareholders regarding this stock.


Universal Health also stands to benefit financially from this acquisition as the deal is expected to boost both its top line and bottom line significantly. Universal Health expects the Cambian Group asset to add approximately £142 million ($175 million) to its revenues. It also anticipates that the buyout will increase its adjusted EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization) by £35 million ($43 million).

Coming to other benefits, the takeover is likely to add 81 behavioral facilities with 1,193 beds to the acquirer, resulting in a total of 102 facilities with 2,250 beds possessed by Universal Health in the U.K. These added facilities with their diversified operations are expected to provide quality care to adults with mental health issues, intellectual disabilities, autism, personality disorders and acquired brain conditions.

Universal Health has been making several acquisitions over the past few years to drive growth. Last year, the company had acquired Alpha Hospitals Holdings Limited - a provider of low and medium secure mental health care facilities and services - in the U.K. In the same year, it bought Orchard Portman House Hospital, a 46-bed behavioral health care facility near Taunton.

However, the prospects of the company are now uncertain as President-elect Donald Trump plans to repeal ObamaCare. The Affordable Care Act (ACA) under Barrack Obama greatly benefited the hospital company by increasing the number of insured population, which led to a decline in bad debts.

A greater number of insured patients meant low incident of bad debts which shielded margins. Now that Trump is likely to repeal most parts of the Act, Universal Health, along with other medical sector stocks like WellCare Health Plans Inc. WCG , Magellan Health Inc. MGLN and UnitedHealth Group, Inc. UNH , to name a few, is deeply concerned.

Zacks Rank

Universal Health presently carries Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here .

Zacks' Top Investment Ideas for Long-Term Profit

How would you like to see our best recommendations to help you find today's most promising long-term stocks? Starting now, you can look inside our portfolios featuring stocks under $10, income stocks, value investments and more. These picks, which have double and triple-digit profit potential, are rarely available to the public. But you can see them now. Click here >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UNITEDHEALTH GP (UNH): Free Stock Analysis Report

WELLCARE HEALTH (WCG): Free Stock Analysis Report

MAGELLAN HLTH (MGLN): Free Stock Analysis Report

UNIVL HLTH SVCS (UHS): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More